In this contributed article, Chris Luoma, Senior Vice President of Global Product Management at Global Healthcare Exchange (GHX), discusses how to achieve the Netflix Effect in healthcare with four best practices. The “Netflix Effect” is the uncanny ability of brands to know exactly what we want, when we want it.
Webinar: Using Third-party Healthcare Data to Accelerate Drug Discovery and Clinical Trial Protocol Design
August 23, 2021 by Leave a Comment
[SPONSORED CONTENT] In this virtual session, AWS Data Exchange will host a panel discussion with thought-leaders from healthcare powerhouse companies like QIAGEN and IBM Watson Health. Learn about the critical role third-party datasets have played in the evolution of the healthcare and life sciences industry. FRIDAY, AUGUST 27 at 11AM PT | 2PM ET
TensorRT 8 Provides Leading Enterprises Fast AI Inference Performance
July 20, 2021 by Leave a Comment
NVIDIA today launched TensorRT™ 8, the eighth generation of the company’s AI software, which slashes inference time in half for language queries — enabling developers to build the world’s best-performing search engines, ad recommendations and chatbots and offer them from the cloud to the edge.
How AI Can Decrease Drug-related Health Equity Challenges
June 5, 2021 by Leave a Comment
Surveyor Health Corporation launched the SurveyorAI platform, a patented technology that drives efficiency and affordability for population medication management using drug knowledge from FDB (First Databank). The company also released the results of a Stanford-guided two-year study and peer reviewed research in the Journal of Managed Care & Specialty Pharmacy.
Microsoft Azure AI for Health Initiatives
March 25, 2021 by Leave a Comment
Let’s invent the future together! Join Microsoft Azure and NVIDIA, grow your expertise, and help shape what’s next for technologists, AI innovators, and creators at GTC 2021.There are amazing opportunities for everyone. Registration is free … what are you waiting for?
Video Highlights: COVID Data Community Profile Report
February 21, 2021 by Leave a Comment
With the COVID-19 data now open to the public, the need for better analysis and aggregation of that information in the U.S. has skyrocketed. If you’re interested in learning more about the current trends impacting the nation and the data that backs it up, check out the Datapalooza COVID Data Community Profile video presentation below, hosted by data journalism firm, CareSet.
Make Your Lazy Data Not So Lazy
February 16, 2021 by 1 Comment
In this contributed article, Kyle McAllister, Practice Director, Data Analytics for Pivot Point Consulting, discusses how many healthcare organizations are willing to invest in new technologies like AI/ML with no plan for what they will do with it once acquired. One of the most pervasive examples of this phenomenon in the big data era is often referred to as “lazy data.” This is data gathered for the sake of gathering data, with no real use case behind it.
Data Science Salon for Healthcare, Finance & Technology
January 25, 2021 by Leave a Comment
insideBIGDATA is pleased to announce that it is a Community Partner for the upcoming “Data Science Salon for Healthcare, Finance & Technology” virtual event (use special discount code: insideBIGDATA20 when registering). DSS Virtual Salon | Applying AI & Machine Learning to Healthcare, Finance & Technology is the only industry conference that brings together specialists in healthcare, finance and technology data science fields to educate each other, illuminate best practices, and innovate new solutions in a casual atmosphere.
Study: Big Data Saves Lives, And Patient Safeguards Are Needed
December 2, 2020 by Leave a Comment
The use of big data to address the opioid epidemic in Massachusetts poses ethical concerns that could undermine its benefits without clear governance guidelines that protect and respect patients and society, a University of Massachusetts Amherst study concludes. In research published in the open-access journal BMC Medical Ethics, Elizabeth Evans, associate professor in the School of Public Health and Health Sciences, sought to identify concerns and develop recommendations for the ethical handling of opioid use disorder (OUD) information stored in the Public Health Data Warehouse (PHD).
Alzheimer’s Disease Data Initiative launches new AD Workbench to foster greater global research innovation and accelerate breakthroughs in Alzheimer’s disease and related dementias
November 22, 2020 by 1 Comment
Launching is the Alzheimer’s Disease Data Initiative (ADDI) and its Alzheimer’s disease (AD) Workbench, a cloud-based platform for scientists to accelerate discoveries and innovations for AD and related dementias. ADDI is a new global effort that aims to advance AD innovation by connecting researchers with the data needed to generate insights and inform the development of improved treatments and diagnostic tools.
